Bach JR, Gonçalves MR, Hon A, Ishikawa Y, De Vito EL, Prado F, Dominguez ME: Changing trends in the management of end-stage neuromuscular respiratory muscle failure. Am J Phys Med Rehabil 2013;92:267Y277.
Bef ore 1953, noninvasive ventilation referred to the use of body ventilators such as the iron lung. 1 Despite their success for continuous ventilatory support, tracheostomy mechanical ventilation (TMV) became the standard for ventilatory support after the 1952 Danish polio epidemic, for which few iron lungs were available. 2 Because TMV freed patients from iron lungs to be mobilized in wheelchairs and facilitated airway secretion management for many, this spread to the United States.
Then, in 1953, Dr John Affeldt wrote, BI some of our physical therapists, in struggling with [iron lung] patients, noticed that they could simply take the positive pressure attachment, apply a small plastic mouthpiece I, and allow that to hang in the patient's mouth I. We even had one patient who has no breathing ability who has fallen asleep and been adequately ventilated by this procedure, so that it appears to work very well, and I think does away with a lot of complications of difficulty of using [invasive] positive pressure. You just hang it by the patients and they grip it with their lips, when they want it, and when they don't want it, they let go of it. It is just too simple. [ 3 Patients who were using body ventilators around the clock began using mouthpiece noninvasive intermittent positive pressure ventilation (NIV) during daytime hours ( Fig. 1 ). Many then used mouthpiece NIV around the clock, refusing to return to body ventilators for sleep. Losing the mouthpiece during sleep could have meant death. The advent of the Bennett Lipseal (Philips-Respironics International Inc, Murrysville, PA) in 1968 prevented this by securing the mouthpiece and diminishing oral air leakage (Fig. 2 ). This permitted the use of NIV for up to full continuous noninvasive ventilatory support (CNVS) as an alternative to TMV. 4 In 1956, the Harris Thompson portable 28-lb Bantam positive pressure ventilator became available. The next year, it was noted, BIf a patient is going to be left a respirator cripple with a very low VC, a tracheotomy may be a great disadvantage. It is very difficult to get rid of a tracheotomy tube when the VC is only 500 or 600 ml and there is no power of coughing, whereas, as we all know, a patient who has been treated in a respirator (body ventilator) from the first can survive and get out of all mechanical devices with a VC of that figure. [ 5 Thus, it was recognized that TMV could result in greater ventilator dependence because of deconditioning, tube-induced secretions, hyperventilation by bypassing upper airway afferents, and, possibly, other factors. 6 Mouthpiece/lip seal NIV was reported to have been used for up to CNVS by 257 patients, most of whom were cared for by Goldwater Memorial Hospital 7 from 1968 through 1987. In 1987, nasal NIV was first used for CNVS for a patient with multiple sclerosis with 100 ml of vital capacity (VC) and no autonomous breathing ability by the same author. 8 This led to a case series 9 reported in 1990 in which nasal NIV was used as part of CNVS. Despite this 1990 publication, no other centers reported using CNVS until Servera et al. 10 did to avert intubations in 2005 and Toussaint et al. 11 did for patients with Duchenne muscular dystrophy (DMD) in 2006. Available since 1984, continuous positive airway pressure (PAP) Bmasks[ were adapted for use with ventilator circuits. 12,13 However, in most centers, patients with progressive neuromuscular respiratory muscle failure continued to be treated with continuous PAP and low spans of bilevel PAP during FIGURE 1 A 66-yr-old woman with no ventilator-free breathing ability and using a 15-mm angled mouthpiece for intermittent positive pressure ventilation, seen here with the mouthpiece in her mouth adjacent to sipand-puff wheelchair controls, since 1954. She has used a Bennett Lipseal interface (Philips-Respironics International Inc, Murrysville, PA) for nocturnal ventilatory support since 1968.
sleep rather than with ventilators that facilitate extending NIV use to CNVS as needed. 14, 15 This continues to result in preventable episodes of ventilatory/respiratory failure (RF). 16Y18 Airway secretion congestion, especially during intercurrent respiratory tract infections, can result in acute RF and intubation. 19 With failure to pass spontaneous breathing trials (SBTs), tracheotomy is conventionally indicated. 20 The ability to increase cough flows by mechanically assisted coughing (MAC), available since 1993, has been reported to help to avoid acute RF 19,21,22 and facilitate successful extubation 23,24 and CNVS. The purpose of this study was to identify the changing trends in the respiratory management of neuromuscular disease (NMD) and to identify and analyze facilitative interventions.
METHODS
Clinicians who had published or presented CNVS outcomes were invited to take part in an expert panel at the 69th Congress of the Mexican Society of Pulmonologists and Thoracic Surgeons, charged with considering the evolution of NMD respiratory management. Respiratory management reviews and consensus articles were identified from MEDLINE. The key words used were neuromuscular disease, Duchenne muscular dystrophy (DMD), amyotrophic lateral sclerosis (ALS), spinal muscular atrophy type 1 (SMA 1), noninvasive ventilation, respiratory management, respiratory care, long term ventilation, and acute respiratory failure. Exclusion criteria were non-English language, editorials, animal subjects, and studies not relevant to the topic. The key interventions associated with achieving CNVS were identified as well as trends in their use over time. Current recommendations were formulated.
Each included publication was read and appraised for methodological rigor according to American College of Chest Physicians task force criteria. 25 Levels of evidence were assigned to each intervention, and ensuing recommendations were graded according to the following: 1A/strong recommendation, high-quality evidence; 1B/strong recommendation, moderate-quality evidence; 1C/strong recommendation, low-quality evidence; 2A/weak recommendation, high-quality evidence; 2B/weak recommendation, moderate-quality evidence; and 2C/ weak recommendation, low-quality evidence. 25
RESULTS
Fifty relevant references were identified including 34 on various NMDs: five on DMD, six on SMA 1, and six on ALS. 17,20,26Y73 Ten references were from the decade of the 1990s and 40 were from the subsequent decades. The following interventions were identified: oxygen therapy, cough peak flow (CPF) evaluation and augmentation, Bair stacking,[ low pressure (e35 cm H 2 O) and high pressure (Q40 cm H 2 O) MAC, bilevel PAP used at both low and high spans, NIV that includes nasal and mouthpiece NIV part time (G23 hrs per day) and full time (923 hrs per day), oximetry feedback for NIV and MAC, elective tracheotomy without meeting the described criteria for tracheotomy, 74Y76 and extubation and decannulation of patients unable to pass SBTs to CNVS. 23
Oxygen Therapy Avoidance
Supplemental oxygen therapy for hypercapnic patients with respiratory muscle weakness can FIGURE 2 A 41-yr-old with Duchenne muscular dystrophy using the Lipseal for nocturnal ventilatory support since the age of 12 yrs and using a 15-mm angled mouthpiece for daytime support since the age of 14 yrs.
www.ajpmr.com decrease ventilatory drive; exacerbate hypercapnia and its symptoms and result in CO 2 narcosis 77 ; render nocturnal bilevel PAP and NIV less effective 78 ; and render oximetry ineffective as a gauge of hypoventilation, airway mucus congestion, atelectasis, and pneumonia. 6, 19, 79 Oxygen supplementation was reported to result in significantly more pneumonias, hospitalizations, and hospitalization days than does NIV or no treatment at all. 77 History Avoidance of supplemental oxygen was recommended by 24 of the 50 early articles, and its use was ignored by the rest except for a 2004 consensus 27 and a 2010 consensus 28 in which it was strongly discouraged despite the absence of randomized controlled trials.
Recommendation
The panel unanimously recommended that oxygen be administered only for acute resuscitation, for hospitalized patients when CNVS and MAC cannot normalize (Q95%) oxyhemoglobin saturation (SpO 2 ) and the patient can readily be intubated, and for euthanasia along with morphine for patients with advanced bulbar ALS who satisfy criteria for but refuse tracheotomy 80 (grade of recommendation: 1C).
Lung Volume Recruitment Techniques: Air Stacking
Air stacking involves the glottis holding consecutively delivered air volumes from a volumecycled ventilator or a manual resuscitator until no more can be held (maximal insufflation capacity). 81 Controlled trials demonstrated significant increases in lung volume recruitment by air stacking. 76 Lung volume recruitment, whether by glottis air stacking or by passive lung insufflations, 82 limits chest wall contractures and lung restriction, increases CPF 83 and voice volume, and promotes lung growth and impedes chest deformity for children with NMD. 6 For small children with paradoxical breathing who cannot air stack, nocturnal NIV has been reported to accomplish this. 84, 85 History Air stacking was cited in 21 of the 50 articles, in only 2 articles before 2002 but in 6 of 12 articles since 2009.
Recommendation
The panel unanimously recommended daily air stacking once the VC is lower than 80% of normal, and, if ineffective because of severe glottic impairment, then passive deep lung insufflations will be used 82 (grade of recommendation for air stacking: 1B). Evaluation of the maximal insufflation capacityY VC difference was also unanimously recommended as an objective, reproducible, quantitative measure of glottic (bulbar-innervated muscle) integrity 86 (grade of recommendation: 1B).
Evaluation and Augmentation of CPF
Manually assisted coughing consists of maximal air stacking followed by a cough-timed abdominal thrust. In controlled trials, it was demonstrated to significantly increase CPF. The CPF, when less than 4.5Y5 liters/sec, indicates the need for manually assisted coughing during periods of airway congestion. 87, 88 Cough flows were increased from 2.5 T 2.0 liters/sec to 4.3 T 1.7 liters/sec by manually assisted coughing. 81 
History
Evaluation and augmentation of CPF were cited in 25 of the 50 articles, only one article before 2000 but in all but five since 2009.
Recommendation
The panel unanimously recommended routine measurement and augmentation of CPF (grade of recommendation: 1A) when it is less than 4.5 liters/ sec (grade of recommendation: 1C).
NIV and Bilevel PAP
Bilevel PAP is conventionally prescribed for patients with NMD whose VCs have decreased lower than 50% and whose bilevel PAP settings were titrated to eliminate Bapneas[ and Bhypopneas[ by polysomnography. When patients deteriorate to require CNVS, however, bilevel PAP becomes inadequate. 26, 89 Most of these devices do not function with direct current and thus cannot be used on a wheelchair, these cannot always be triggered by infants and others with little VC, air stacking to increase cough flows is not possible, 6 and inspiratory muscle rest is suboptimal at less than full support settings, so these patients eventually develop RF and undergo tracheotomy rather than be managed by CNVS. 90, 91 History Three reviews and consensuses of respiratory management of NMD did not mention NIV or bilevel PAP. The remaining 47 suggested a variety of indications for introducing nocturnal bilevel PAP, with 11 recommending high-span PAP (inspiratory PAP minus expiratory PAP spans 910 cm H 2 O), and 29, only nocturnal low-span PAP. Controlled studies demonstrated a statistically significant prolongation of survival for several months using nocturnal bilevel PAP, but none reported extending the use of bilevel PAP to CNVS.
Recommendation
Because bilevel PAP cannot be used for air stacking, expiratory PAP is counterproductive for assisting weak respiratory muscles, and, because portable ventilators eventually become necessary for CNVS, the panel recommended that all patients with the ability to air stack use nocturnal NIV rather than bilevel PAP (grade of recommendation: 1C).
Continuous Noninvasive Intermittent Positive Pressure Ventilatory Support
This can be provided during sleep via nasal or oronasal interface and during daytime hours via mouthpiece except for those whose lips are too weak to grab it, in which case, nasal prongs are used. 6, 92 CNVS has been reported to have been used successfully as an alternative to TMV for 760 patients from 21 centers 93 and for patients for up to 58 yrs ( Fig. 1 ).
History
The use of some daytime mouthpiece NIV was recommended in 16 of 47 articles and, for up to CNVS, in 10 articles, but none noted that tracheostomy could be avoided by CNVS, especially when the patients are intubated. Extubation of Bunweanable[ patients to CNVS has thus far only been reported in four centers. 7,10,11,26
Recommendation
Because of the limitations of bilevel PAP and the eventual need for CNVS, the panel unanimously recommended that assist-control volume-cycling NIV be used for patients capable of air stacking and that pressure-cycling NIV be used otherwise. The grade of recommendation is 1A for using ventilators for CNVS because of the extremely large and consistent magnitude of the treatment effect, 25 that is, no randomized controlled trials are possible to demonstrate prolonged survival because discontinuance of CNVS can only result in death for patients without the autonomous ability to breathe. 94, 95 However, the panel unanimously recommended the use of nocturnal bilevel PAP or pressure-cycling NIV for patients with bulbar ALS who hypoventilate during sleep but cannot air stack (grade of recommendation: 1A). 75 Mechanically Assisted Coughing MAC is defined as mechanical insufflationexsufflation (e.g., Cough Assist; Philips-Respironics Inc, Murraysville, PA) with an exsufflation-timed abdominal thrust. The mechanical in-exsufflator delivers positive pressure to full clinical chest expansion then negative pressure to maximal lung emptying via an oronasal interface or an invasive airway tube. 96 Like withdrawal of CNVS for patients with 0 ml of VC, withdrawal of MAC from patients with productive airways but who are unable to cough necessarily results in RF, most often from pneumonia in the left lung fields because airway suctioning misses the left mainstem bronchus more than 90% of the time. 97 The only randomized controlled trial of MAC vs. invasive airway suctioning significantly favored the former. 98 The use of MAC has been reported to be critical to avoid RF, hospitalization, and intubation for patients with chest infections 21,74,99,100 and to permit extubation/ decannulation of patients failing SBTs. 23 The patients who benefit the most from MAC are those whose bulbar muscle function is insufficient to permit optimal air stacking for assisted CPF (94.5Y5 liters/min) but is adequate to maintain airway patency. 76 
History
Only 12 articles mentioned in-exsufflation use at the insufflation and exsufflation pressures considered effective by this panel (935 cm H 2 O). 101Y103 Nineteen articles recommended low pressures, 3 noted no settings, and 15 did not mention it. No articles cited the use of MAC via invasive airway tubes.
Recommendation
The panel unanimously recommended that MAC be used, whether noninvasively or via invasive airway tube, for all NMD patients with CPF less than 5 liters/sec 21 to treat airway congestion (grade of recommendation: 1A).
Extubation and Decannulation
Despite CNVS and MAC, aspiration and intercurrent respiratory tract infections can result in pneumonia and RF, and early tracheotomy has been proposed to Bminimize respiratory complications.[ 104Y106 Conventionally, ventilator weaning is considered necessary for extubation. Tracheostomy for endstage respiratory management and extubation failure was cited in 46 of the 50 articles, and none described the extubation or the decannulation of patients who could not pass SBTs. However, a 2010 publication reported successful extubation of 155 of 157 unweanable patients with NMD to CNVS and MAC in two centers using a NMDspecific protocol. 23 Decannulation of unweanable patients to CNVS and MAC has also been described for more than 100 patients with NMD and spinal cord injury (SCI). 24,107,108
History
Only one consensus article in 2010 recommended three extubation attempts to CNVS before resorting to tracheostomy but implied that the latter would eventually become necessary. 28
Recommendation
The panel unanimously recommended that all patients with NMD and SCI meeting the criteria, whether weanable or not, be offered extubation or decannulation to CNVS and MAC as described 24,107 (grade of recommendation: 1A). Likewise, the panel unanimously recommended tracheotomy only for patients who cannot maintain an SpO 2 of greater than or equal to 95% despite CNVS and MAC, 74 that is, essentially, only for bulbar ALS (grade of recommendation: 1C).
Oximetry Feedback Protocol
The protocol consists of using an oximeter for feedback to maintain an SpO 2 of greater than or equal to 95% by using ambient air CNVS and MAC as needed, for example, during intercurrent respiratory tract infections and after extubation/decannulation. 19, 23 No randomized controlled trials were done, but patients requiring CNVS during respiratory tract infections and having oxyhemoglobin desaturations because of airway congestion have never been previously reported to have been managed at home and to have no invasive cannulation.
History
The protocol was recommended in 8 of the 50 articles but in only 1 article before 2003. 74, 109 
Recommendation
The panel unanimously agreed that, because it is impossible to develop RF with an SpO 2 of greater than or equal to 95% in ambient air, patients with ineffective CPF be taught the protocol to avoid RF 21,22 (grade of recommendation: 1C).
DISCUSSION
Mechanisms by which the recommended interventions can improve the clinical picture include relieving symptoms; resting the respiratory muscles and decreasing metabolic demand; increasing tidal volumes and relieving hypercapnia; resetting chemoreceptors; opening atelectatic areas; maintaining airway patency; improving ventilation/perfusion matching; maintaining lung and chest wall range of motion and compliance; improving cough flows and airway clearance; and, most importantly, assisting, supporting, and substituting for respiratory muscle function. 6, 79 Bilevel PAP use at spans of less than 10 cm H 2 O may not adequately achieve these goals and cannot provide CNVS. Nocturnal NIV at full ventilatory support settings is typically spontaneously extended into daytime hours and eventually around the clock, thereby averting hospitalizations for RF and tracheostomy tubes, and has been used by some patients for up to 58 yrs (Fig. 1) .
In 1993, indication for tracheotomy was described as the need for NIV more than 15 hrs a day. 29 That consensus had only one dissenting voice who argued for CNVS (the first author of this article). Now, however, others from that group are using CNVS rather than tracheostomy for patients with NMD. 104 None of the five centers that extubate unweanable patients had any of their 385 patients with DMD on CNVS undergo tracheotomy except when they required critical care and were lost to the expert center. 110Y113 Noninvasive management is invariably preferred more than tracheostomy by patients for safety, convenience, appearance, comfort, speech, sleep, swallowing, and general acceptability, 114 and a recent controlled trial demonstrated significantly longer survival by CNVS than by TMV for DMD. 113 Longterm complications of tracheostomy include greater ventilator dependence, 107 ineffective cough, and more frequent pneumonias and hospitalizations than with CNVS. 115, 116 Whereas some recent consensuses recommended most of the cited interventions, all gave rationales to resort to tracheotomy. Indeed, a 2010 DMD consensus group 28 was the first to make all of the important recommendations but concluded that tracheostomy was indicated when preferred by the patient and clinician, when NIV was unsuccessful, when there was inability of Bthe local medical infrastructure to support NIV,[ for three extubation failures despite optimal use of NIV or bilevel PAP and MAC, and for aspiration of airway secretion to the extent that the SpO 2 remains less than 95% despite optimal use of NIV and MAC. However, that panel of 11 experts had only 1 who came from a center where patients with NMD who failed SBTs are extubated without tracheotomy and who did not agree that tracheostomy would become necessary, except for the latter two scenarios.
In this panel, every member has long-term CNVS users and at least five members are from centers that routinely extubate and decannulate unweanable patients with NMD. 23 None of the 760 properly trained and equipped CNVS-dependent patients reported by this panel ever opted for or Bpreferred[ elective tracheotomy without meeting the ALS criteria for it. 74 The authors suggest that only patients not offered with CNVS and MAC at optimal settings prefer tracheostomy. Other than for patients with severe mental impairment, no one on this panel has encountered a patient with DMD who could Bnot successfully use or tolerate CNVS.[ The authors are also unaware of the inability of local medical infrastructure to support NIV except in countries where ventilator use is not funded. Five of 101 patients with DMD in one center have been dependent on CNVS for more than 20 yrs, with none of 40 intercurrent extubation attempts on them having failed. 93, 113 None, therefore, have failed three extubation attempts. 74 Unfortunately, the tracheotomy recommendations of the 2010 consensus can be used by any clinician to justify tracheostomy rather than organize a support system of comprehensive instruction, equipping, and training in noninvasive management. 99 Such a premise perpetuates expensive, invasive care, with need for higher technology and skilled nursing and more institutionalization that diminishes quality-of-life and that is rarely, if ever, preferred by patients.
For typical SMA 1, survival has thus far been extended to up to 182 yrs by up to CNVS from as early as 4 mos of age for 60 patients with SMA 1 (Fig. 3) . 117, 118 Despite these outcomes, consensuses of experts as recent as 2009 report that 95% of children with SMA 1 die before 18 mos of age, with a mean age of death at 25 wks, and none reported using CNVS. 34, 35 Many articles continue to be published on palliative care for ALS, with none thus far referring to prolonging life by CNVS. 36,80,119Y124 Because about 40% of patients with ALS, or 335 reported by this panel, can survive using CNVS for a mean of 11 mos, 93, 109 palliative care precepts are inappropriate for properly equipped and trained patients with adequate personal care before they meet the criteria for tracheostomy. 74 For most non-ALS NMD diagnoses, palliative care interventions are distinctly inappropriate because oxygen therapy and narcotics hasten death. Thus, Bpalliative respiratory care[ for patients with NMD perpetuates the misconception that NIV is only for symptom relief and not for CNVS to prolong survival. 
